» Articles » PMID: 15579630

Neurokinins and Inflammatory Cell INOS Expression in Guinea Pigs with Chronic Allergic Airway Inflammation

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study we evaluated the role of neurokinins in the modulation of inducible nitric oxide synthase (iNOS) inflammatory cell expression in guinea pigs with chronic allergic airway inflammation. In addition, we studied the acute effects of nitric oxide inhibition on this response. Animals were anesthetized and pretreated with capsaicin (50 mg/kg sc) or vehicle 10 days before receiving aerosolized ovalbumin or normal saline twice weekly for 4 wk. Animals were then anesthetized, mechanically ventilated, given normal saline or N(G)-nitro-l-arginine methyl ester (l-NAME, 50 mg/kg ic), and challenged with ovalbumin. Prechallenge exhaled NO increased in ovalbumin-exposed guinea pigs (P < 0.05 compared with controls), and capsaicin reduced this response (P < 0.001). Compared with animals inhaled with normal saline, ovalbumin-exposed animals presented increases in respiratory system resistance and elastance and numbers of total mononuclear cells and eosinophils, including those expressing iNOS (P < 0.001). Capsaicin reduced all these responses (P < 0.05) except for iNOS expression in eosinophils. Treatment with l-NAME increased postantigen challenge elastance and restored both resistance and elastance previously attenuated by capsaicin treatment. Isolated l-NAME administration also reduced total eosinophils and mononuclear cells, as well as those cells expressing iNOS (P < 0.05 compared with ovalbumin alone). Because l-NAME treatment restored lung mechanical alterations previously attenuated by capsaicin, NO and neurokinins may interact in controlling airway tone. In this experimental model, NO and neurokinins modulate eosinophil and lymphocyte infiltration in the airways.

Citing Articles

Effect of VAChT reduction on lung alterations induced by exposure to iron particles in an asthma model.

Dos Santos T, Righetti R, do Nascimento Camargo L, Leick E, Fukuzaki S, de Campos E J Inflamm (Lond). 2024; 21(1):24.

PMID: 38961398 PMC: 11223391. DOI: 10.1186/s12950-024-00399-6.


Effects of a Peptide Derived from the Primary Sequence of a Kallikrein Inhibitor Isolated from (pep-BbKI) in an Asthma-COPD Overlap (ACO) Model.

da Silva L, Barbosa J, Joao J, Fukuzaki S, do Nascimento Camargo L, Dos Santos T Int J Mol Sci. 2023; 24(14).

PMID: 37511021 PMC: 10379932. DOI: 10.3390/ijms241411261.


The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.

Li M, Yang T, He R, Li A, Dang W, Liu X Int J Chron Obstruct Pulmon Dis. 2020; 15:3025-3037.

PMID: 33244228 PMC: 7685357. DOI: 10.2147/COPD.S273422.


Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in Mice.

Almeida-Reis R, Theodoro-Junior O, Oliveira B, Oliva L, Toledo-Arruda A, Bonturi C Biomed Res Int. 2017; 2017:8287125.

PMID: 28466019 PMC: 5390602. DOI: 10.1155/2017/8287125.


Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Steinhoff M, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett N Physiol Rev. 2014; 94(1):265-301.

PMID: 24382888 PMC: 3929113. DOI: 10.1152/physrev.00031.2013.